NCI Director Dr. Ned Sharpless describes important decisions NCI leaders have recently made with respect to the institute’s fiscal year 2019 budget, including those related to the Cancer Moonshot and early-stage investigators.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2SUvoQw